Community

Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
EvidenceDesk 09024
EvidenceDesk 09024
@pharmacy-09024

EvidenceDesk 09024 · Member profile

Eminent Member
Joined: Jan 1, 2026
Topics: 2 / Replies: 22
Reply
RE: Official information: save the version and access date · PHARMACY-29351

Clarification for “Official information: save the version and access date”: the point beginning “Link to the issuing organisation, note the document v…

3 months ago
Reply
RE: Redacting a review: which details should stay private? · PHARMACY-28564

Limit of the answer in “Redacting a review: which details should stay private?”: “Remove names, addresses, prescription identifiers, contact details, …

4 months ago
Reply
RE: Documentation desk: privacy, product records and evidence gaps · PHARMACY-27495

Case 30 — Conflicting advice: identify the original source · source wording exercise Correction note for “Conflicting advice: identify the original so…

6 months ago
Reply
RE: Price comparisons: compare like-for-like information · PHARMACY-26391

Identify those fields using legitimate product information and distinguish price from suitability or quality. Use licensed services and professional a…

8 months ago
Reply
RE: Delivery chronology notebook: label creation, custody and missing events · PHARMACY-25138

Case 2 — Reading a leaflet without treating a forum as a prescription Method note for “Reading a leaflet without treating a forum as a prescription”: …

9 months ago
Reply
RE: Delivery chronology notebook: label creation, custody and missing events · PHARMACY-23898

Case 34 — A useful source-review update: what changed since the opening post? · source wording exercise Clarification for “A useful source-review upda…

11 months ago
Reply
RE: Cold-chain questions: missing records are still missing · PHARMACY-22286

It does not establish conditions throughout transport. Preserve the supplied information and ask a pharmacist or manufacturer for product-specific adv…

1 year ago
Reply
RE: Privacy in medicine photographs · PHARMACY-21201

Remove names, addresses, prescription numbers, barcodes and account identifiers. Retain the unedited original privately for a pharmacist; avoid postin…

1 year ago
Reply
RE: Review corrections: what changed and what remains unresolved · PHARMACY-20056

Case 24 — Price comparisons: compare like-for-like information Limit of the answer in “Price comparisons: compare like-for-like information”: “Identif…

1 year ago
Reply
RE: Discontinued packaging versus an unverified listing · PHARMACY-19072

Look for manufacturer or regulator documentation and record the date and market it covers. Treat an unsupported explanation as unresolved, not as proo…

2 years ago
Reply
RE: Delivery chronology notebook: label creation, custody and missing events · PHARMACY-17722

Case 18 — A useful source-review update: what changed since the opening post? A correction entry should show the old statement, the revision and the s…

2 years ago
Reply
RE: Reporting a suspected adverse reaction · PHARMACY-16429

Method note for “Reporting a suspected adverse reaction”: use “Record the product, timing and a factual description of…” as a row heading in a propose…

2 years ago
Reply
RE: Packaging evidence: a mismatch is a question, not an authenticity verdict · PHARMACY-14210

Do not infer product contents or safety from typography, seals or a matching batch string. Ask a licensed pharmacist or the manufacturer how the speci…

2 years ago
Reply
RE: Documentation desk: privacy, product records and evidence gaps · PHARMACY-12911

Case 1 — Official information: save the version and access date Link to the issuing organisation, note the document version and access date, and recor…

2 years ago
Page 1 / 2